No attachments available.
Cancer Trials Support Unit
Contact and place of performance
Chris Shih
USA
Contract Title: Cancer Trials Support Unit (CTSU) The IDIQ contract number 75N91022D00013 was awarded against solicitation number 75N91021R00021. The maximum value of the IDIQ contract is $548,000,000 if all options are exercised. Task Areas Awarded: Task Area 1: Project Kick-off Meeting/Transition Activities Task Area 3: Awareness, Education, and Training (AET)
The National Institutes of Health, National Cancer Institute, awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract to support the Cancer Trials Support Unit (CTSU) under solicitation 75N91021R00021. The awarded contract, 75N91022D00013, carries a maximum potential value of $548,000,000 if all options are exercised. Performance takes place within the United States, managed by the contracting office in Bethesda, Maryland, under the primary point of contact Chris Shih.
The scope of this award covers specific task areas including Task Area 1 for project kick-off meetings and transition activities, as well as Task Area 3 for awareness, education, and training (AET). These services fall under NAICS code 541715 for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and PSC AN13 for Health R&D Services; Health Care Services; Experimental Development.
This award notice, published on July 28, 2022, identifies the acquisition as an SBP (Small Business Program) set-aside. The contract serves the research and development needs of the National Institutes of Health to facilitate oncology clinical trials and related support services. There are no attachments associated with this award notice.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.